Genprex, Inc. (GNPX) Financials
GNPX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 16.6 million | 4.3 million |
2023-06-30 | 15.9 million | 3.9 million |
2023-03-31 | 23.3 million | 4.8 million |
2022-12-31 | 25.1 million | 2.8 million |
GNPX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -4.8 million | 1.5 million |
2023-06-30 | -8.1 million | 1.5 million |
2023-03-31 | -7.0 million | 1.3 million |
2022-12-31 | -4.6 million | 1.5 million |
GNPX Net Income
No data available :(
GNPX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 11.7 million | - | - |
2023-06-30 | 10.0 million | - | - |
2023-03-31 | 18.1 million | - | - |
2022-12-31 | 21.0 million | - | - |
GNPX Shares Outstanding
GNPX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 21756 | 4.6 million | 3.2 million | - |
2023-06-30 | 20000 | 4.0 million | 4.1 million | - |
2023-03-31 | 19627 | 5.3 million | 4.0 million | - |
2022-12-31 | 19998 | 3.3 million | 3.5 million | - |
GNPX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 3724 |
2023-06-30 | - | 3837 |
2023-03-31 | - | 4016 |
2022-12-31 | - | 23.8 million |
GNPX
Price: $2.50
52 week price:
Earnings Per Share: -22.56 USD
P/E Ratio: -0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 159356
Market Capitalization: 5.1 million